PR

Prestige BioPharma Limited

Develops affordable biosimilars and novel antibody drugs for life-threatening diseases.

950210 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Singapore
Address:
21 BIOPOLIS ROAD #04-24 NUCLEOS, SINGAPORE
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Prestige BioPharma Limited is a biopharmaceutical company specializing in the development of biosimilars and innovative, first-in-class antibody drugs. The company pursues a dual-track strategy focused on both creating affordable, high-quality biosimilars to enhance patient access and discovering novel therapeutics and vaccines for life-threatening diseases. Its operations cover the full development lifecycle, from discovery and research to clinical development, registration, and commercialization. Prestige BioPharma aims to become a global innovation hub by fostering collaboration and advancing biopharmaceutical technologies.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Prestige BioPharma Limited and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-19 00:00
Audit Report / Information
감사보고서제출
Korean 21.8 KB
2025-09-19 00:00
Annual Report
사업보고서 (2025.06)
Korean 3.7 MB
2025-09-16 00:00
Regulatory News Service
[기재정정]단일판매ㆍ공급계약체결
Korean 12.8 KB
2025-09-11 00:00
Pre-Annual General Meeting Information
[기재정정]주주총회소집결의
Korean 17.3 KB
2025-09-11 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 136.7 KB
2025-09-09 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 9.5 KB

Automate Your Workflow. Get a real-time feed of all Prestige BioPharma Limited filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Prestige BioPharma Limited via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
GENOLUTION INC. Logo
Develops molecular diagnostic and RNAi solutions for genetic testing and life sciences research.
South Korea 225220
Genome&Company Logo
Clinical-stage biopharma developing cancer therapies using microbiome, immune inhibitors, and ADCs.
South Korea 314130
Develops molecular diagnostics using DNA methylation biomarkers for early cancer detection.
South Korea 228760
Genomtec S.A. Logo
Develops a mobile platform for rapid, precise genetic diagnostics at the point-of-care.
Poland GMT
GENOTECH CORP. Logo
A biotech firm offering gene synthesis, genome analysis, and biopharmaceutical products globally.
South Korea 066830
Gentian Diagnostics ASA Logo
Develops & manufactures IVD immunoassays for human & veterinary disease diagnostics.
Norway GENT
GI Innovation Inc. Logo
Develops fusion protein biologics for oncology, allergic, and metabolic diseases.
South Korea 358570
GlaxoSmithKline PLC Logo
A biopharmaceutical company developing vaccines and specialty medicines to prevent and treat disease.
United Kingdom GSK
GL Pharm Tech Corp. Logo
Develops improved drugs and generics, and licenses proprietary drug formulation technologies.
South Korea 204840
GNI  Group Ltd. Logo
Biopharma firm developing novel drugs for cancer and inflammatory diseases using genetics.
Japan 2160

Talk to a Data Expert

Have a question? We'll get back to you promptly.